Business
Immutep doses First Patient in TACTI-002 Phase II Trial
Immutep doses First Patient in TACTI-002 Phase II Trial
About this update from Immutep Ltd
[{"type":"text","content":"Immutep Ltd has released a press release. View Attachment","length":222,"tagName":"div"}]